India POC Immunoassay Analyzers Market

Competition Benchmarking for Point of Care Immunoassay Analysers in India

Region:Asia

Author(s):Jalaj and Ritika Garg

Product Code:KR1365

Download Sample Report download
Buy the Full ReportStarting from $4750
Published on

July 2023

Total pages

50

About the Report

About the Report

Country Overview:

India is one of the fastest-growing economies in the world, and this growth extends to its healthcare sector as well. The country had been steadily expanding its healthcare infrastructure and capabilities, particularly in response to the COVID-19 pandemic.

Point-of-care testing (POCT), including the use of immunoassay analyzers, had been increasing in demand due to the need for rapid, accurate testing in a variety of settings. These devices are used to detect and quantify specific analytes in blood or other body fluids, aiding in diagnosing and managing diseases.

Given the vast population of India and the considerable challenges in reaching rural and remote communities, point-of-care testing has significant potential. These analyzers allow for decentralized healthcare, bringing diagnostics closer to the patient and enabling faster decision-making. The immunoassay analyzer market has been seeing significant growth in India from past 5 years.

Companies mentioned in the India POC Immunoassays Analyzer Competition benchmarking are - Quidel, BioMerieux, Getein Biotech, Boditech and SD Biosensors. All these companies have a strong presence in the Indian POC immunoassay analyzers market, each offering a unique mix of advantages in terms of product range, turnaround time, ease of maintenance, and cost.

Saudi Arabia Macroeconomic Indicators

India POC Immunoassay Analyzers Competition Benchmarking Analysis

  • Players like Quidel, BioMerieux, Getein Biotech, Boditech, and SD Biosensors offering a wide range of analyzers. These analyzers provide various testing options, including cardiac markers, infection marker testing, and coagulation testing.
  • Turnaround times vary among the different analyzers, with some offering quick results in minutes. The level of automation also varies, with some analyzers being fully automated, while others are semi-automated or manual.
  • One key factor for healthcare facilities to consider is the cost, as it can vary significantly between analyzers and tests.
  • Quidel, BioMerieux, Getein Biotech, Boditech, and SD Biosensors each have their strengths and unique offerings, allowing healthcare facilities to choose the best fit for their specific needs.


Key Trends by Market Segment:

By Hospital ICU Bed Capacity: Boditech acquired the most dominant player in the Hospital ICU Bed Capacity segment in 2021 in India POC immunoassay analyzers sector, capturing maximum hospitals having maximum capacity of 20 ICU beds or less.

By Hospital ICU Bed Capacity

By Testing Volume: Boditech has the maximum testing volume compared to other companies, having the major portion of testing volume in the range of 100 – 300 test per month in 2021.

Boditech's captured a major portion of the testing volume due to its extensive testing menu and the ability to cater to a wide range of medical parameters. With analyzers like the Standard and MultiCare offering, including cardiac markers, infection markers, and more, Boditech's products appealed to diverse healthcare facilities, including hospitals, clinics, and diagnostic centers.

India POC Immunoassay Analyzers Market

Competitive Landscape:

The competitive landscape of the India POC Immunoassay Analyzers Market is shaped by several key parameters. Firstly, segmentation based on Hospital ICU Bed Capacity highlights the market's responsiveness to varying healthcare infrastructure, with solutions tailored to different capacities. Secondly, the segmentation by Testing Volume underscores the market's adaptability to differing testing demands, with players offering scalable solutions for high, medium, and low-volume facilities. Lastly, competition based on Testing Volume and the specific type of Tests conducted showcases the market's specialization, with companies catering to the diverse diagnostic needs of hospitals. This multifaceted competitive landscape fosters innovation and strategic differentiation, driving players to devise solutions that align with hospital capacities, testing volumes, and diagnostic requirements.

Competitive Landscape for India POC Immunoassay Analyzers Market


Recent Developments:

    • In February 2022, Boditech Med and SphingoTec Close Global Licensing Agreement for Kidney Function Biomarker Proenkephalin A 119-159 (penKid).
    • In April 2023, JMI Laboratories and bioMérieux announced Antimicrobial Resistance Diagnostics Partnership. They announced that they together will work to improve and develop microbiology diagnostic tools.

Scope Of The Report

Scope of the Report

Competition Benchmarking India POC immunoassays Analyzers

By Companies

Quidel Corporation

BioMérieux

Getein Biotech

Boditech

SD Biosensors

Quidel Corporation

Quidel Installed Bases

ØIAA POC Installed Base (in numbers)

ØNumber of Tests in a year

By Hospital ICU Bed Capacity

Ø20 beds or less

Ø20-50 beds

Ø50 beds and above

By Testing Volume

ØBelow 100 tests per month

Ø100-300 tests per month

Ø300-500 tests per month

Ø500-1,000 tests per month

Ø1,000 and above

Testing Volume basis type of Tests

ØTroponin I

ØSOB Panel

ØCardio III

ØCardio II

ØTOX

ØBNP, ProBNP and others

List of hospitals

BioMerieux

Installed Bases

ØIAA POC Installed Base (in numbers)

ØNumber of Tests in a year

By Installed Place

ØCentral Lab

ØPOC

By Hospital ICU Bed Capacity

Ø20 beds or less

Ø20-50 beds

Ø50 beds and above

By Testing Volume

ØBelow 100 tests per month

Ø100-300 tests per month

Ø300-500 tests per month

Ø500-1,000 tests per month

Ø1,000 and above

Testing Volume basis type of Tests

ØCardiac Markers

ØFertility Markers

ØVitamin D

ØTumour markers and others

List of hospitals

Getein Biotech

Installed Bases

Ø IAA POC Installed Base (in numbers)

Ø Number of Tests in a year

By Hospital ICU Bed Capacity

Ø 20 beds or less

Ø 20-50 beds

Ø 50 beds and above

By Testing Volume

Ø Below 100 tests per month

Ø 100-300 tests per month

Ø 300-500 tests per month

Ø 500-1,000 tests per month

Ø 1,000 and above

Testing Volume basis type of Tests

Ø Cardiac Testing (Troponin, CKMB, D-Dimer, Myoglobin etc.)

Ø Hormonal Paraneters (β-HCG, T3, T4, TSH etc.)

Ø Hba1c

Ø Infectious Parameters (CRP, PCT etc.)

Ø Others

List of hospitals

Boditech

Installed Bases

Ø  IAA POC Installed Base (in numbers)

Ø  Number of Tests in a year

By Hospital ICU Bed Capacity

Ø  20 beds or less

Ø  20-50 beds

Ø  50 beds and above

By Testing Volume

Ø  Below 100 tests per month

Ø  100-300 tests per month

Ø  300-500 tests per month

Ø  500-1,000 tests per month

Ø  1,000 and above

Testing Volume basis type of Tests for i-chrome

ØCRP

ØHba1c

ØPSH

ØVitamin

ØOthers

Testing Volume basis type of Tests for AFIAS

Ø Troponin I

Ø CRP

Ø PCT

Ø NTproBNP

Ø D-Dimer

Ø Others

List of hospitals

SD Biosensor

Installed Bases

Ø  IAA POC Installed Base (in numbers)

Ø  Number of Tests in a year

By Hospital ICU Bed Capacity

Ø  20 beds or less

Ø  20-50 beds

Ø  50 beds and above

By Testing Volume

Ø  Below 100 tests per month

Ø  100-300 tests per month

Ø  300-500 tests per month

Ø  500-1,000 tests per month

Ø  1,000 and above

Testing Volume basis type of Tests

Ø Dengue, chikenguniya, malaria

Ø Troponin

Ø Thyroid

Ø CRP

Ø Others

List of hospitals

Customize This Report for You
Need a Specific Data? Like: Pricing Analysis Competitor Analysis Benchmarking Data Business Planning
Customize Now!

Products

Products

Key Target Audience – Organizations and Entities Who Can Benefit by Subscribing This Report:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Primary Healthcare Centers
  • Investors and venture capitalists
  • Research institutions and universities
  • Pharmaceuticals Companies
  • Medical Device Distributors
  • Non-Profit Health Organizations
  • Telemedicine Providers
  • Industry Associations
  • Consulting Agencies
  • Government Bodies & Regulating Authorities


Time Period Captured in the Report:

  • Time Period: 2021-2022


Companies

Major Players Mentioned in the Report:

  • Quidel Corporation
  • BioMérieux
  • Getein Biotech
  • Boditech
  • SD Biosensor

Table of Contents

Table of Contents

1. Executive Summary

2. Quidel Market Sheet

2.1 Quidel Market Size Basis Installed Base, 2021-2022

2.2 Quidel Market Segmentation

2.3 Quidel Market Positioning

2.4 Quidel Testing Menu

2.5 List of Hospitals

3. BioMerieux Market Sheet

3.1 bioMerieux Market Size Basis Installed Base, 2021-2022

3.2 bioMerieux Market Segmentation

3.3 bioMerieux Market Positioning

3.4 Testing Menu

3.5 List of Hospitals

4. Getein Biotech Market Sheet

4.1 Getein Biotech Market Size Basis Installed Base, 2021-2022

4.2 Getein Biotech Market Segmentation

4.3 Getein Biotech Market Positioning

4.4 Testing Menu

4.5 List of Hospitals

5. Boditech Market Sheet

5.1 Boditech Market Size Basis Installed Base, 2021-2022

5.2 Boditech Market Segmentation

5.3 Boditech Market Positioning

5.4 Testing Menu

5.5 List of Hospitals

6. SD Biosensor Market Sheet

6.1 SD Biosensor Market Size Basis Installed Base, 2021-2022

6.2 SD Biosensor Market Segmentation

6.3 SD Biosensor Market Positioning

7.Testing Menu

7.1 List of Hospitals

8. Competition Sheet

8.1 Market Dynamics (Product, Portfolio, Quick TAT, Ease of Maintenance & Inventory, 

8.2 Manual VS semi-automated vs Fully automated, Cost of Device and Cost per test)

8.3 SWOT Analysis

9. Research Methodology

9.1 Market Definitions and Assumptions and Abbreviations

9.2 Consolidated Research Approach

9.3 Primary Research Approach

9.4 Limitation and Future Conclusion

Disclaimer

Contact Us

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Research Methodology

Research Methodology

Step:1 Identifying Key Variables:

All the major entities of all the players are made by referring to multiple secondary and proprietary databases to perform desk research around market to collate industry level information.

Step:2 Market Building:

Collating statistics on India POC Immunoassay for 2021-2022, on product profile, cost of devices, cost of tests, etc.

Step:3 Validating and Finalizing:

conducting CATIs with industry experts belonging to different companies to validate statistics and seek operational and financial information from company representatives.

Step:4 Research output:

Our team has approached major companies mentioned in the report and understanded nature of product segments and sales, consumer preference and other parameters, which supported us validate statistics.

Research Methodology for India POC Immunoassay Analyzers Market

Frequently Asked Questions

Frequently Asked Questions

01 How big is the India POC Immunoassay Analyzers Market?

The India POC Immunoassay Analyzers market is valued at USD 34 Billion in 2022.  

02 What is the future market size of the India POC Immunoassay Analyzers Market?

The future market size of the India POC Immunoassay Analyzers Market is expected to reach USD 47 Billion in the forecasted period of 2023-2028 with a CAGR of 5.5%. 

03 Who are the major players in the India POC Immunoassay Analyzers market? 

Quidel Corporation, BioMérieux, Getein Biotech, Boditech, and SD Biosensors are some of the prominent companies operating in the India POC Immunoassay Analyzers market.

04 What are the latest trends in the India POC Immunoassay Analyzers market? 

Increasing demand for multiplex analyzers, the development of portable and handheld analyzers, and integration with information technology (IT) systems are some of the latest trends in the India POC Immunoassay Analyzers market.  

05 Which segment is dominating the India POC Immunoassay Analyzers market in the End-User category?

Hospitals and clinics are leading the India POC Immunoassay Analyzers market in the End-User category followed by pharmaceutical and biotechnology companies.

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022